Correction: Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib – Which One, How and For Whom? - Lukac, Stefan; Pfister, Kerstin; Schäffler, Henning; Leinert, Elena; Fink, Angelina; Rack, Brigitte; Fink, Visnja; Janni, Wolfgang; Heublein, Sabine (Geburtshilfe und Frauenheilkunde, 2025)